|Bid||84.89 x 100|
|Ask||86.76 x 100|
|Day's Range||84.87 - 86.13|
|52 Week Range||73.59 - 89.72|
|PE Ratio (TTM)||23.47|
|Earnings Date||Feb 20, 2018|
|Forward Dividend & Yield||1.84 (2.15%)|
|1y Target Est||91.23|
Medtronic plc (NYSE:MDT) delivered a less impressive 9.83% ROE over the past year, compared to the 13.25% return generated by its industry. An investor may attribute an inferior ROE toRead More...
New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke DUBLIN - January 16, 2018 - Medtronic plc (NYSE:MDT) today announced that the company`s Neurovascular business ...
The competition for full-size pickup truck customers in the U.S. is heating up as Ram and Chevrolet roll out brawny-looking new models at the Motor City's auto show
More foreign companies were in Beijing’s crosshairs Friday after including regions like Tibet and Taiwan in a list of independent countries on their websites.
Chinese regulators rebuked fashion brand Zara, Delta Air Lines and medical device maker Medtronic on Friday for calling Taiwan a country on their websites in a fresh show of Beijing's acute sensitivity ...
China's aviation authority on Friday demanded an apology from Delta Air Lines (DAL.N) for listing Taiwan and Tibet as countries on its website, while another government agency took aim at Inditex-owned (ITX.MC) fashion brand Zara and medical device maker Medtronic Plc (MDT.N) for similar issues. The moves follow a regulator's decision on Thursday to suspend Marriott International Inc's (MAR.O) Chinese website for a week to punish the world's biggest hotel chain for listing Tibet, Taiwan, Hong Kong and Macau as separate countries in a customer questionnaire.
China's aviation authority on Friday demanded an apology from Delta Air Lines for listing Taiwan and Tibet as countries on its website, while another government agency took aim at Inditex-owned fashion brand Zara and medical device maker Medtronic Plc for similar issues. The moves follow a regulator's decision on Thursday to suspend Marriott International Inc's Chinese website for a week to punish the world's biggest hotel chain for listing Tibet, Taiwan, Hong Kong and Macau as separate countries in a customer questionnaire.
Therapy Delivered via the Medtronic SynchroMed(TM) II Infusion System DUBLIN - January 11, 2018 - Medtronic plc (NYSE:MDT) today announced the publication of results from the `Spasticity In Stroke-Randomised ...
Stryker's 52-Week High: Should You Expect Further Upside?SYK stock at 52-week high On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4. As of January 9, 2018, SYK stock is trading higher than its 50-day moving average of $155 as well as the 200-day moving average of $148.1. Stryker traded at a 52-week low of $117.6 on January 9, 2017. The company’s one-year stock return is ~35% as of January 9, 2018.
SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) ...
Medical-device giant Medtronic announced a multibillion-dollar restructuring program Monday that will impact an undisclosed number of employees. Medtronic expects the plan to result in more than $3 billion in annual gross savings by the end of its 2022 fiscal year. The restructuring will affect an undisclosed number of employees, but Medtronic's total employee count will hold steady, the company said in an SEC filing.
Medtronic PLC (NYSE:MDT) announced its Q2 2018 results in late November. If you only looked at its top- and bottom-line, I’m pretty confident your takeaway wasn’t to buy yourself MDT stock as an early Christmas present. Don’t get me wrong, a $2 billion profit is nothing to sneeze at, but a big chunk of that quarterly gain resulted from the sale of several of its businesses to Cardinal Health Inc (NYSE:CAH) producing a $697 million after-tax gain.
Government bodies like Medicare, Medicaid and the U.S. FDA are signaling that remote patient monitoring is going to be a huge industry over the coming decade; agencies improving the environment for medical ...
As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment DUBLIN - January 9, 2018 - Medtronic ...
Medtronic Plc on Monday unveiled a restructuring plan that it expects will help it save $500 million to $700 million annually over the next five years. Chief Executive Omar Ishrak said the company was confident about mid-single digit revenue growth in the short term. Medtronic said in November it expected revenue growth to be in the range of 4-5 percent in fiscal 2018, and adjusted earnings to increase 9 to 10 percent.
Shares fall by double-digits during a quiet month for the robotic surgery upstart. Is there something to worry about, or is the pullback just market noise?